The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced Bacterial Genetics: A Manual for Genetic Engineering
Davis, R. W., Botstein, D., & Roth, J. R. (1980) · Cold Spring Harbor Laboratory eBooks · Cited by 2,904
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,078
A New Method for the Extraction of R Lipopolysaccharides
Galanos, C., Lüderitz, O., & Westphal, O. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00601.x · Cited by 1,859
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Self-citationToward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome)
Bone, R. C. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490240060037 · Cited by 513
Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome
Dinarello, C. A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140081040 · Cited by 405
Measurement of invasion by gentamicin resistance
Elsinghorst, E. A. (1994) · Methods in Enzymology · doi:10.1016/0076-6879(94)36030-8 · Cited by 342
Streilein, J. W. (1995) · Science · doi:10.1126/science.270.5239.1158 · Cited by 295
O'Callaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S., & Dougan, G. (1988) · Infection and Immunity · doi:10.1128/iai.56.2.419-423.1988 · Cited by 286
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275
A lethal role for lipid A in Salmonella infections
Khan, S. A., Everest, P., Servos, S., Foxwell, N., Zähringer, U., Brade, H., Rietschel, E. T., Dougan, G., Charles, I. G., & Maskell, D. J. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00952.x · Cited by 212
Gram-negative sepsis: a dilemma of modern medicine
Bone, R. C. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.57 · Cited by 208
Virulence and vaccine potential of phoP mutants of Salmonella typhimurium
Galán, J. E., & Curtiss, R. (1989) · Microbial Pathogenesis · doi:10.1016/0882-4010(89)90085-5 · Cited by 202
Clementz, T., Zhou, Z., & Raetz, C. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10353 · Cited by 199
Chromosomal transformation of Escherichia coli recD strains with linearized plasmids
Russell, C. B., Thaler, D. S., & Dahlquist, F. W. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.5.2609-2613.1989 · Cited by 163
SalmonellaFlagellin Induces Tumor Necrosis Factor Alpha in a Human Promonocytic Cell Line
Ciacci-Woolwine, F., Blomfield, I. C., Richardson, S. H., & Mizel, S. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1127-1134.1998 · Cited by 154
Kovach, N. L., Yee, E., Munford, R. S., Raetz, C. R., & Harlan, J. M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.1.77 · Cited by 139
Karow, M. L., & Georgopoulos, C. P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.3.702-710.1992 · Cited by 109
Sklar, M. D., Tereba, A., Chen, B. D. ‐., & Walker, W. S. G. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041250307 · Cited by 100
Saltzman, D. A., Heise, C. P., Hasz, D. E., Zebede, M., Kelly, S. M., Curtiss, R., Leonard, A. S., & Anderson, P. M. (1996) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1996.11.145 · Cited by 100
Agonists and antagonists for lipopolysaccharide-induced cytokines
Flad, H., Loppnow, H., Rietschel, E. T., & Ulmer, A. J. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80346-3 · Cited by 65
Chabalgoity, J. A., Khan, C. M. A., Nash, A. A., & Hormaeche, C. E. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.426965.x · Cited by 62
Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase
Engel, H., Smink, A. J., van Wijngaarden, L., & Keck, W. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.20.6394-6403.1992 · Cited by 45
Su, G., Brahmbhatt, H. N., de Lorenzo, V., Wehland, J., & Timmis, K. N. (1992) · Microbial Pathogenesis · doi:10.1016/0882-4010(92)90013-e · Cited by 23
Immunotherapy of a plasmacytoma with attenuated salmonella
Eisenstein, T. K., Bushnell, B., Meissler, J. J., Dalal, N. F., Schafer, R., & Havas, H. F. (1995) · Medical Oncology · doi:10.1007/bf01676710 · Cited by 21
Cited by
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
Metadata
- Authors
- Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S. L., Luo, X., Miller, S. I., Zheng, L.-M., King, I., Pawelek, J. M., & Bermudes*, D.
- Venue
- Nature Biotechnology
- Published
- 1999-01
- Volume
- 17
- Issue
- 1
- Pages
- 37-41
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- DOI
- 10.1038/5205
- OpenAlex
- W1595241211
- Cited by
- 476
- References
- 25
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.